BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 28070716)

  • 1. Pharmacokinetics and Saturable Absorption of Gabapentin in Nursing Home Elderly Patients.
    Ahmed GF; Bathena SP; Brundage RC; Leppik IE; Conway JM; Schwartz JB; Birnbaum AK
    AAPS J; 2017 Mar; 19(2):551-556. PubMed ID: 28070716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of immediate release, extended release, and gastric retentive gabapentin formulations in healthy adults
.
    Swearingen D; Aronoff GM; Ciric S; Lal R
    Int J Clin Pharmacol Ther; 2018 May; 56(5):231-238. PubMed ID: 29633699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of gabapentin after a single day and at steady state following the administration of gastric-retentive- extended-release and immediate-release tablets: a randomized, open-label, multiple-dose, three-way crossover, exploratory study in healthy subjects.
    Gordi T; Hou E; Kasichayanula S; Berner B
    Clin Ther; 2008 May; 30(5):909-16. PubMed ID: 18555937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic/Pharmacodynamic Relationship of Gabapentin in a CFA-induced Inflammatory Hyperalgesia Rat Model.
    Larsen MS; Keizer R; Munro G; Mørk A; Holm R; Savic R; Kreilgaard M
    Pharm Res; 2016 May; 33(5):1133-43. PubMed ID: 26780452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of age and gender on single-dose pharmacokinetics of gabapentin.
    Boyd RA; Türck D; Abel RB; Sedman AJ; Bockbrader HN
    Epilepsia; 1999 Apr; 40(4):474-9. PubMed ID: 10219274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of gabapentin in paediatric patients with uncontrolled seizures.
    Tallian KB; Nahata MC; Lo W; Tsao CY
    J Clin Pharm Ther; 2004 Dec; 29(6):511-5. PubMed ID: 15584938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of MDR1 G2677T/A polymorphism on pharmacokinetics of gabapentin in healthy Korean subjects.
    Kang HA; Cho HY; Lee YB
    Arch Pharm Res; 2007 Jan; 30(1):96-101. PubMed ID: 17328248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of oral gabapentin in greyhound dogs.
    Kukanich B; Cohen RL
    Vet J; 2011 Jan; 187(1):133-5. PubMed ID: 19854080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic drug monitoring of gabapentin].
    Tribut O; Bentué-Ferrer D; Verdier MC;
    Therapie; 2010; 65(1):57-60. PubMed ID: 20205997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetics of gabapentin in healthy Korean subjects with influence of genetic polymorphisms of ABCB1.
    Tran P; Yoo HD; Ngo L; Cho HY; Lee YB
    J Pharmacokinet Pharmacodyn; 2017 Dec; 44(6):567-579. PubMed ID: 29018999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of gabapentin in horses.
    Dirikolu L; Dafalla A; Ely KJ; Connerly AL; Jones CN; ElkHoly H; Lehner AF; Thompson K; Tobin T
    J Vet Pharmacol Ther; 2008 Apr; 31(2):175-7. PubMed ID: 18307511
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics of gabapentin in a novel gastric-retentive extended-release formulation: comparison with an immediate-release formulation and effect of dose escalation and food.
    Chen C; Cowles VE; Hou E
    J Clin Pharmacol; 2011 Mar; 51(3):346-58. PubMed ID: 20484610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gabapentin synergistically interacts with topiramate in the mouse maximal electroshock seizure model: an isobolographic analysis.
    Luszczki JJ; Czuczwar SJ
    Pharmacol Rep; 2006; 58(6):944-54. PubMed ID: 17220554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic of gabapentin 600 mg tablet in Thai healthy subjects.
    Wittayalertpanya S; Chompootaweep S; Thaworn N; Khemsri W; Prompila N; Sayankuldilok N; Punyasang W
    J Med Assoc Thai; 2012 Apr; 95(4):583-9. PubMed ID: 22612015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin.
    Bockbrader HN; Wesche D; Miller R; Chapel S; Janiczek N; Burger P
    Clin Pharmacokinet; 2010 Oct; 49(10):661-9. PubMed ID: 20818832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of a novel approach for dose individualization in pharmacotherapy using gabapentin in a proof of principles study.
    Blau GE; Orcun S; Laínez JM; Reklaitis GV; Suvannasankha A; Fausel C; Anaissie EJ
    Pharmacotherapy; 2013 Jul; 33(7):727-35. PubMed ID: 23553679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PHARMACOKINETIC PROPERTIES OF A SINGLE ADMINISTRATION OF ORAL GABAPENTIN IN THE GREAT HORNED OWL (BUBO VIRGINIANUS).
    Yaw TJ; Zaffarano BA; Gall A; Olds JE; Wulf L; Papastavros E; Coetzee JF
    J Zoo Wildl Med; 2015 Sep; 46(3):547-52. PubMed ID: 26352959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and bioequivalence evaluation of two gabapentin preparations after a single oral dose in healthy Korean volunteers.
    Cho HY; Kang HA; Lee YB
    Int J Clin Pharmacol Ther; 2006 Aug; 44(8):386-92. PubMed ID: 16961169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isobolographic analysis of interaction between drugs with nonparallel dose-response relationship curves: a practical application.
    Luszczki JJ
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Apr; 375(2):105-14. PubMed ID: 17333129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between patient age and gabapentin serum concentration-to-dose ratio: a preliminary multivariate analysis.
    Armijo JA; Pena MA; Adín J; Vega-Gil N
    Ther Drug Monit; 2004 Dec; 26(6):633-7. PubMed ID: 15570187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.